Mismatch Repair-Proficient
3 clinical trials · Condition
◉ Watch Mismatch Repair-Proficient
| Record | Firm | Date |
|---|---|---|
| Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer (NCT05263492) | Virginia Commonwealth University | 2022-04-01 |
| Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer (NCT04119830) | Roswell Park Cancer Institute | 2022-02-01 |
| Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer (NCT05160727) | Zhejiang Cancer Hospital | 2021-10-01 |
Track Mismatch Repair-Proficient automatically
Every clearance here is in the API, with alerts when new ones post.